Aqilion Resumes Development of its TAK1-Program
05 Feb 2025 //
PHARMAWEB
Aqilion to Present at Biotech ShowcaseTM During JP Morgan Week
17 Dec 2024 //
PHARMAWEB
Aqilion announces pre-clinical licensing collaboration agreement with Merck
16 Feb 2023 //
PR NEWSWIRE
Merck hands Swedish biotech €10M cash to develop anti-inflammatory drugs
16 Feb 2023 //
ENDPTS
Aqilion strengthens the company’s pipeline through the acquisition of a phase-1
05 Dec 2021 //
AQILION
Aqilion strengthens its operational team in line with the company’s
01 Mar 2021 //
CISION
Aqilion sells shareholdings in portfolio company Glactone Pharma
09 Dec 2019 //
PRESS RELEASE